Heparin in the Prevention of Deep Vein Thrombosis after Myocardial Infarction
- 20 May 1972
- Vol. 2 (5811), 436-438
- https://doi.org/10.1136/bmj.2.5811.436
Abstract
A trial of continuous intravenous heparin in the prevention of deep vein thrombosis was undertaken in 48 patients who had suffered a myocardial infarction. Of the 24 control patients who did not receive heparin seven (29%) developed calf vein thrombosis as detected by the radioactive fibrinogen technique. None of the 24 heparinized patients had any evidence of venous thrombosis. This difference is significant at the 1% level.This publication has 19 references indexed in Scilit:
- GLUCOSE THERAPY IN SHORT-BOWEL SYNDROMEThe Lancet, 1971
- PREVENTION OF POSTOPERATIVE DEEP-VEIN THROMBOSIS WITH PERIOPERATIVE SUBCUTANEOUS HEPARINThe Lancet, 1971
- PREVENTION OF FATAL POSTOPERATIVE THROMBOEMBOLISM BY HEPARIN PROPHYLAXISThe Lancet, 1970
- LEG-VEIN THROMBOSIS FOLLOWING MYOCARDIAL INFARCTIONThe Lancet, 1970
- Portable heparin injector.1970
- 125I-LABELLED FIBRINOGEN TEST ADAPTED FOR ROUTINE SCREENING FOR DEEP-VEIN THROMBOSISThe Lancet, 1970
- Management of deep vein thrombosis.BMJ, 1970
- NATURAL HISTORY OF POSTOPERATIVE DEEP-VEIN THROMBOSISThe Lancet, 1969
- A NEW CORONARY PROGNOSTIC INDEXThe Lancet, 1969
- A CORONARY PROGNOSTIC INDEX FOR GRADING THE SEVERITY OF INFARCTIONHeart, 1962